Crispr Therapeutics shares owned by Van Eck Associates Corp.
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Van Eck Associates Corp.
from 13F filings
Historical chart of Van Eck Associates Corp. investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Van Eck Associates Corp. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Van Eck Associates Corp.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $5.4M | 84k | 64.71 |
| 2025-06-30 | $4.1M | 83k | 48.81 |
| 2025-03-31 | $2.8M | 83k | 33.95 |
| 2024-12-31 | $3.3M | 83k | 39.26 |
| 2024-09-30 | $71k | 1.5k | 45.93 |
| 2024-06-30 | $4.3M | 80k | 54.05 |
| 2024-03-31 | $4.9M | 72k | 68.23 |
| 2023-12-31 | $4.2M | 68k | 62.63 |
| 2023-09-30 | $3.3M | 73k | 45.20 |
| 2023-06-30 | $4.3M | 77k | 56.33 |
| 2023-03-31 | $3.8M | 83k | 45.40 |
| 2022-12-31 | $3.8M | 93k | 40.46 |
| 2022-09-30 | $5.2M | 79k | 65.56 |
| 2022-06-30 | $7.7M | 126k | 60.77 |
| 2022-03-31 | $7.2M | 114k | 62.77 |
| 2021-12-31 | $7.9M | 104k | 75.75 |
| 2021-09-30 | $11M | 96k | 111.91 |
| 2021-06-30 | $17M | 104k | 161.89 |
| 2021-03-31 | $15M | 119k | 121.85 |